Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

One Bench at a Time

Mammoth Biosciences raises $23M for its CRISPR-based disease detection engine

After completing their graduate work at Stanford, Trevor Martin and Ashley Tehranchi took 2 benches at MBC BioLabs to launch Mammoth Biosciences. Now, only seven months later, they and their colleagues have completed a $23M Series A. Mammoth Biosciences is turning UC Berkeley professor, Jennifer Doudna’s latest CRISPR discoveries into an innovative diagnostics platform. The research portion of the company will include Berkeley PhD students Janice Chen and Lucas Harrington at the helm.

MBC BioLabs and Mission Bay Capital are thrilled to have been able to help this terrific team of entrepreneurial scientists go from start to data and financing in such short order.

Upcoming Event

  • A Welcome Party for Newcomers! Location: 953 Indiana Street, San Francisco

    15:30-17:00
    08/31/2018
    Please join us for a celebration to welcome all new companies to the MBC BioLabs family! Come and meet the new faces in the building and enjoy some food!

Address

953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287
Map

Sign-Up for our Newsletter